Handok - Asset Resilience Ratio

Latest as of December 2025: 0.38%

Handok (002390) has an Asset Resilience Ratio of 0.38% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩3.00 Billion

≈ $2.03 Million USD Cash + Short-term Investments

Total Assets

₩790.75 Billion

≈ $535.88 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Handok's Asset Resilience Ratio has changed over time. Check how strategically is Handok's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Handok's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Handok worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩3.00 Billion	0.38%
Total Liquid Assets	₩3.00 Billion	0.38%

Asset Resilience Insights

Limited Liquidity: Handok maintains only 0.38% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Handok Industry Peers by Asset Resilience Ratio

Compare Handok's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%

Annual Asset Resilience Ratio for Handok (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Handok.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.38%	₩3.00 Billion ≈ $2.03 Million	₩790.75 Billion ≈ $535.88 Million	0.00pp
2024-12-31	0.38%	₩3.00 Billion ≈ $2.03 Million	₩788.56 Billion ≈ $534.39 Million	-0.06pp
2023-12-31	0.44%	₩3.50 Billion ≈ $2.37 Million	₩790.34 Billion ≈ $535.60 Million	+0.10pp
2022-12-31	0.34%	₩3.00 Billion ≈ $2.03 Million	₩871.11 Billion ≈ $590.34 Million	-0.25pp
2021-12-31	0.59%	₩5.00 Billion ≈ $3.39 Million	₩841.56 Billion ≈ $570.31 Million	-0.63pp
2020-12-31	1.22%	₩10.00 Billion ≈ $6.78 Million	₩818.93 Billion ≈ $554.97 Million	-0.66pp
2019-12-31	1.89%	₩14.12 Billion ≈ $9.57 Million	₩748.67 Billion ≈ $507.36 Million	+1.49pp
2018-12-31	0.40%	₩2.61 Billion ≈ $1.77 Million	₩652.62 Billion ≈ $442.27 Million	+0.38pp
2017-12-31	0.02%	₩113.22 Million ≈ $76.73K	₩639.35 Billion ≈ $433.28 Million	--

pp = percentage points

About Handok

KO:002390 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$78.88 Million

₩116.40 Billion KRW

Market Cap Rank

#20022 Global

#1013 in Korea

Share Price

₩8960.00

Change (1 day)

+1.13%

52-Week Range

₩6700.00 - ₩12360.00

All Time High

₩38942.94